Key Takeaways
- • Private equity healthcare deals have declined 18.5% year-over-year (Q2 2025 to Q2 2026), with management services organization (MSO) deals dropping 36% from 111 to 71 transactions, according to PitchBook research.
- • At least 79 bills addressing private equity transactions in healthcare were documented across 25 states as of early 2026, with over a dozen states now requiring PE firms to notify regulators of planned acquisitions.
- • Oregon's 2025 corporate practice of medicine law, effective January 2026, prohibits PE ownership of local health clinics through MSOs and blocks the "friendly physician" model, establishing a regulatory template being replicated nationwide.
- • Five states—California, Indiana, Minnesota, New Mexico, and Oregon—currently have direct or indirect PE regulation programs, while additional states including Connecticut, Maine, Vermont, and Indiana are pursuing legislation to curb private equity and other financialized healthcare ownership.
- • Increased state regulatory scrutiny is lengthening transaction timelines, escalating deal costs and complexity, and undermining PE serial roll-up acquisition strategies in healthcare services.
Summary
A cascade of state-level legislation is substantially constraining private equity's ability to consolidate healthcare services, marking a significant shift in the regulatory environment for healthcare investing. According to PitchBook's latest industry analysis, private equity healthcare deals nationwide declined 18.5% over the past year comparing Q2 2025 to Q2 2026, with management services organization deals—a key acquisition vehicle for PE—experiencing a sharper contraction of nearly 36%, falling from 111 to 71 transactions during the same period.
The regulatory catalyst for this slowdown centers on state laws targeting PE ownership structures and corporate practice of medicine restrictions. Oregon's 2025 corporate practice of medicine law, which took effect in January 2026, exemplifies the legislative trend. The law prohibits corporations and private equity firms from owning local health clinics through management services organizations and prevents these entities from maintaining majority control over clinical practices while retaining administrative or billing operations—effectively closing the "friendly physician" loophole that allowed PE firms to circumvent physician-ownership requirements.
As of early 2026, regulatory momentum has accelerated across the country. At least 79 bills addressing PE transactions and investor-backed ownership in healthcare were documented across 25 states, according to policy analysis. Over a dozen states have passed laws requiring private equity to notify state authorities about planned healthcare transactions, with some imposing approval requirements. Maine recently implemented a one-year moratorium on hospital purchases by private equity and real estate investment trusts. Meanwhile, lawmakers in Connecticut, Vermont, Indiana, and California are actively pursuing additional legislation to restrict private equity and financialized ownership models. Currently, only five states—California, Indiana, Minnesota, New Mexico, and Oregon—maintain direct or indirect PE regulation programs, indicating substantial room for additional state-level restrictions.
The regulatory tightening is directly impacting deal economics and execution. PitchBook's report attributed the decline in PE healthcare deals to "tighter regulations slowing deal processes." These regulatory barriers are lengthening transaction timelines, increasing deal costs and complexity, and fundamentally constraining the serial roll-up acquisition strategies that have historically defined PE healthcare consolidation. For institutional investors and fund managers focused on healthcare services, this legislative momentum represents a structural headwind requiring significant portfolio monitoring and deal structure recalibration.
The regulatory catalyst for this slowdown centers on state laws targeting PE ownership structures and corporate practice of medicine restrictions. Oregon's 2025 corporate practice of medicine law, which took effect in January 2026, exemplifies the legislative trend. The law prohibits corporations and private equity firms from owning local health clinics through management services organizations and prevents these entities from maintaining majority control over clinical practices while retaining administrative or billing operations—effectively closing the "friendly physician" loophole that allowed PE firms to circumvent physician-ownership requirements.
As of early 2026, regulatory momentum has accelerated across the country. At least 79 bills addressing PE transactions and investor-backed ownership in healthcare were documented across 25 states, according to policy analysis. Over a dozen states have passed laws requiring private equity to notify state authorities about planned healthcare transactions, with some imposing approval requirements. Maine recently implemented a one-year moratorium on hospital purchases by private equity and real estate investment trusts. Meanwhile, lawmakers in Connecticut, Vermont, Indiana, and California are actively pursuing additional legislation to restrict private equity and financialized ownership models. Currently, only five states—California, Indiana, Minnesota, New Mexico, and Oregon—maintain direct or indirect PE regulation programs, indicating substantial room for additional state-level restrictions.
The regulatory tightening is directly impacting deal economics and execution. PitchBook's report attributed the decline in PE healthcare deals to "tighter regulations slowing deal processes." These regulatory barriers are lengthening transaction timelines, increasing deal costs and complexity, and fundamentally constraining the serial roll-up acquisition strategies that have historically defined PE healthcare consolidation. For institutional investors and fund managers focused on healthcare services, this legislative momentum represents a structural headwind requiring significant portfolio monitoring and deal structure recalibration.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.